Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy

It is a matter of current interest which rifaximin-α regimens in patients with liver cirrhosis and minimal hepatic encephalopathy are the most efficient. Study objective: to evaluate the effect of various rifaximin-α regimens for 12 months on clinical and laboratory parameters and quality of life in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakulin, Igor G., Ivanova, Kristina N., Eremina, Elena Y., Marchenko, Natalya V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606376/
https://www.ncbi.nlm.nih.gov/pubmed/37892060
http://dx.doi.org/10.3390/diagnostics13203239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606376/
https://www.ncbi.nlm.nih.gov/pubmed/37892060
http://dx.doi.org/10.3390/diagnostics13203239

Ejemplares similares